Tactile Systems

Tactile Systems Technology, Inc. is a medical technology company. It develops and provides innovative medical devices for the treatment of chronic diseases at home. The firm focus on advancing the standard of care in treating chronic diseases in the home setting to improve patient outcomes and quality of life and help control rising healthcare expenditures. The company was founded on January 30, 1995 and is headquartered in Minneapolis, MN.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Tactile Systems reports strong Q4 earnings, eyes growth and innovation

Tactile Systems delivered impressive Q4 2022 results with strong revenue growth, positive net income, and operational advancements, positioning the company for future success.
Strategic priorities for 2023 focus on sales team productivity, new product innovation, and operational efficiency, highlighting a commitment to sustained growth and market leadership.
Challenges include managing sales force turnover, supply chain constraints, and financial complexities post-2023, requiring proactive solutions and strategic decision-making.
Opportunities lie in capitalizing on revenue growth momentum, new product developments, and achieving an expanded adjusted EBITDA profile, signaling potential for continued success and value creation.

Tactile Systems reports robust Q1 growth, focuses on innovation

Tactile Systems delivered strong financial performance and operational advancements in Q1 2023, showcasing growth potential and a commitment to innovation and patient care.
While facing challenges in supply chain readiness and operational efficiency, the company's strategic focus on enhancing Medicare processes and product development presents opportunities for future success.
Overall, Tactile Systems' earnings call highlighted a positive trajectory with increased revenue guidance, product innovation, and a dedication to improving patient outcomes and support.

Tactile Systems (TCMD) reports strong Q2 earnings and growth outlook

Tactile Systems (TCMD) showcased robust financial performance, operational efficiency gains, and strategic talent additions in Q2 2023.
While facing challenges like AffloVest sales slowdown, the company raised revenue guidance and expects strong profitability with adjusted EBITDA of $25-27 million for 2023.
Opportunities lie in the head and neck trial's potential impact on revenue, Kylee app engagement benefits, and strategic priorities driving growth.

Tactile Systems reports revenue growth and strategic initiatives progress

Tactile Systems' Q3 performance showed revenue growth and improved profitability, supported by strategic initiatives and margin improvement efforts.
While facing challenges in AffloVest sales and patient acquisition, the company is optimistic about opportunities in therapy expansion and operational enhancements.
Consistent price increases and focus on technology-driven efficiencies are key strengths, with a focus on achieving ambitious 2025 targets.
Overall, Tactile Systems is navigating challenges while capitalizing on opportunities for growth and operational optimization.

Tactile Systems posts robust Q4 results, eyes growth opportunities

Tactile Systems delivered strong financial performance in Q4 2023, with revenue and net income growth. The company provided optimistic revenue guidance for 2024 and outlined strategic priorities for driving growth and enhancing customer experience. Challenges include anticipated headwinds and limited margin gains in the short term.

Tactile Systems reports Q1 growth, doubles EBITDA, eyes tech expansion

Tactile Systems reported solid financial performance with revenue growth and doubled adjusted EBITDA.
The company is strategically investing in tech advancements, new products, and expanding sales channels.
Challenges include addressing declining airway clearance revenues and optimizing sales rep impact.
Opportunities lie in expanding clinical trials, enhancing product user experience, and leveraging tech investments.

Tactile Systems (TCMD) reports robust Q2 earnings amidst Medicare challenges

Tactile Systems' Q2 2024 performance reflects solid financial growth and strategic initiatives. While facing challenges from Medicare documentation requirements, the company is focused on adapting to regulatory changes. Opportunities lie in capital allocation strategies, technology advancements, and market expansion efforts.

Tactile Systems reports Q3 growth, faces documentation challenges and opportunities

Tactile Systems delivered solid Q3 performance with revenue growth and improved EBITDA, despite challenges in sales productivity.
The company's strategic strengths lie in strong market demand, product innovation, and a shareholder-friendly capital allocation strategy.
Navigating challenges related to regulatory changes and operational efficiency while capitalizing on growth opportunities will be key for future success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tactile Systems Technology, Inc. engages in developing and providing medical devices for the treatment of underserved chronic diseases. It provides lymphedema solutions and offers Flexitouch Plus and Entre Plus systems products. The company was founded on January 30, 1995 and is headquartered in Minneapolis, MN.

Full Year Revenue Increased 11% Year-Over-Year; Full Year Net Income Increased 260%; Full Year Adjusted EBITDA Increased 62% Full Year Revenue Increased 11% Year-Over-Year; Full Year Net Income Increased 260%; Full Year Adjusted EBITDA Increased 62%

Tactile Systems Technology, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Outlook

MINNEAPOLIS, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will participate in the following upcoming investor conferences:

Tactile Medical to Participate in Upcoming Investor Conferences in February and March

BuildABear

Canadian Solar

Dine Brands Global

Movado Group

SurgePays

Titan Machinery

In theory, the concept of targeting deep value stocks seems simple enough: find the companies in various sectors with the lowest multiples of your choosing and voila! Deep value.

7 Overlooked Deep Value Stocks Worthy of Your Attention

MINNEAPOLIS, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that fourth quarter and fiscal year 2023 financial results will be released before the market opens on Tuesday, February 20th.

Tactile Medical to Release Fourth Quarter and Fiscal Year 2023 Financial Results on February 20, 2024

Andersons

JAKKS Pacific

RCM Technologies

Let's take a look at four top-ranked stocks, JAKK, ANDE, RCMT and TCMD, with stellar net profit margins that can help create a winning portfolio.

4 Top-Ranked Stocks With Solid Net Profit Margin to Buy Now

Artivion

iShares MSCI Emerging Markets ex China ETF

This trading bot buys stocks bought by US politicians; Here are its biggest holdings

Tactile Systems Technology, Inc. (NASDAQ:TCMD ) Q3 2023 Earnings Call Transcript November 6, 2023 5:00 PM ET Company Participants Daniel Reuvers - President & Chief Executive Officer Elaine Birkemeyer - Chief Financial Officer Conference Call Participants Simran Kaur - Piper Sandler Ryan Zimmerman - BTIG Margaret Kaczor - William Blair & Company Suraj Kalia - Oppenheimer & Co. Inc. Operator Welcome ladies and gentlemen to the Third Quarter of Fiscal Year 2023 Earnings Conference Call for Tactile Medical. At this time all participants have been placed in a listen-only mode.

Tactile Systems Technology, Inc. (TCMD) Q3 2023 Earnings Call Transcript

MINNEAPOLIS, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the third quarter ended September 30, 2023.

Tactile Systems Technology, Inc. Reports Third Quarter 2023 Financial Results; Updates Full Year 2023 Outlook

Barrett Business Services

Modine Manufacturing

Let's take a look at four top-ranked stocks, MOD, ANDE, BBSI and TCMD, with stellar net profit margins that can help to create a winning portfolio.

Snap Up These 4 Stocks With Solid Net Profit Margin for Gains

Tactile Systems Technology (TCMD) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Tactile Systems Technology (TCMD) Surges 5.8%: Is This an Indication of Further Gains?

MINNEAPOLIS, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that third quarter of fiscal year 2023 financial results will be released after the market closes on Monday, November 6.

Tactile Medical to Release Third Quarter of Fiscal Year 2023 Financial Results on November 6, 2023

MINNEAPOLIS, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the appointment of Vindell Washington, M.D. to the Company's Board of Directors (“Board”), effective October 2, 2023.

Tactile Medical Appoints Vindell Washington, M.D. to Board of Directors

Investors need to pay close attention to Tactile Systems (TCMD) stock based on the movements in the options market lately.

Is the Options Market Predicting a Spike in Tactile Systems (TCMD) Stock?

MINNEAPOLIS, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will participate in the following upcoming investor conferences:

Tactile Medical to Participate in Two Upcoming Conferences in September

MINNEAPOLIS, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will participate in the 2023 Wells Fargo Healthcare Conference, which is being held at the Encore Boston Harbor in Boston, MA from September 6th - 8th. Management will participate in a fireside chat on Thursday, September 7th at 8:45 a.m. Eastern Time.

Tactile Medical to Present at the 2023 Wells Fargo Healthcare Conference

Tactile Systems Technology, Inc. (NASDAQ:TCMD ) Q2 2023 Earnings Conference Call August 7, 2023 5:00 PM ET Company Participants Daniel Reuvers - President & Chief Executive Officer Elaine Birkemeyer - Chief Financial Officer Conference Call Participants Simran Kaur - Piper Sandler Margaret Kaczor - William Blair & Company Suraj Kalia - Oppenheimer & Co. Inc. Operator Welcome, ladies and gentlemen, to the Second Quarter of Fiscal Year 2023 Earnings Conference Call for Tactile Medical. [Operator Instructions] Please note that this conference call is being recorded and will be available on the company's website for replay shortly.

Tactile Systems Technology, Inc. (TCMD) Q2 2023 Earnings Call Transcript

Tactile Systems Technology (TCMD) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of a loss of $0.07 per share. This compares to loss of $0.14 per share a year ago.

Tactile Systems Technology (TCMD) Q2 Earnings and Revenues Beat Estimates

MINNEAPOLIS, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the second quarter ended June 30, 2023.

Tactile Systems Technology, Inc. Reports Second Quarter 2023 Financial Results; Updates Full Year 2023 Outlook

MINNEAPOLIS, July 18, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the appointment of Sherri Ferstler to the position of Senior Vice President of Sales, effective July 31, 2023. Ms. Ferstler will succeed Eric Pauls, who will be resigning from the Company, effective July 28, 2023.

Tactile Medical Appoints Sherri Ferstler as Senior Vice President of Sales

MINNEAPOLIS, June 29, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that second quarter of fiscal year 2023 financial results will be released after the market closes on Monday, August 7.

Tactile Medical to Release Second Quarter of Fiscal Year 2023 Financial Results on August 7, 2023

Tactile Systems has outstripped peers with a tremendous rally starting in November last year. The market has no doubt increased its expectations for the company given the higher market valuation.

Tactile Systems: Lymphedema, AffloVest Markets Continue Adding Value

MINNEAPOLIS, May 23, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will participate in the William Blair 43rd Annual Growth Stock Conference, which is being held at the Loews Chicago Hotel in Chicago, IL from June 6th – 8th. Management will host a presentation with investors on Tuesday, June 6th at 8:00 a.m. Central Time.

Tactile Medical to Present at the William Blair 43rd Annual Growth Stock Conference

Tactile Systems Technology, Inc. (NASDAQ:TCMD ) Q1 2023 Earnings Conference Call May 8, 2023 5:00 PM ET Company Participants Daniel Reuvers - President and Chief Executive Officer Elaine Birkemeyer - Chief Financial Officer Conference Call Participants Simran Kaur - Piper Sandler Margaret Kaczor - William Blair & Company Ryan Zimmerman - BTIG Suraj Kalia - Oppenheimer & Co. Inc. Operator Welcome, ladies and gentlemen, to the First Quarter of Fiscal Year 2023 Earnings Conference Call for Tactile Medical. At this time, all participants have been placed in a listen-only mode.

Tactile Systems Technology, Inc. (TCMD) Q1 2023 Earnings Call Transcript

MINNEAPOLIS, May 08, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the first quarter ended March 31, 2023. First Quarter 2023 Summary: Total revenue increased 23% year-over-year to $58.8 million Lymphedema products revenue increased 22% year-over-year Airway clearance products revenue increased 24% year-over-year Operating loss of $3.8 million versus $14.9 million in Q1 2022 Non-GAAP operating loss of $2.2 million versus $5.4 million in Q1 2022 Net loss of $1.9 million versus $15.6 million in Q1 2022 Adjusted EBITDA of $0.5 million versus a $2.6 million loss in Q1 2022 First Quarter 2023 Highlights: Raised $34.6 million of net proceeds via an underwritten public equity offering Launched Entre® Plus, a next-generation version of the Entre system with enhanced features Appointed Carmen Volkart to the Company's Board of Directors Appointed Elaine Birkemeyer to the position of Chief Financial Officer “We were delighted to achieve revenue growth of over 20% in both our product lines, as our sales teams grew increasingly productive.

Tactile Systems Technology, Inc. Reports First Quarter 2023 Financial Results; Raises Full Year 2023 Outlook

The world's foremost artificial intelligence stock trading algorithm, An-E, predicts that Tactile Systems Technology (NASDAQ: TCMD ) stock will gain 5.6% by May 30. An-E (pronounced Annie) has made this kind of prediction before.

News for Tactile Systems Stock (TCMD)